MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Ribometrix Announces $30 Million Series A Funding to Advance Pipeline of RNA-Targeting Small Molecule Therapies.
Brennan CaruthersNovember 13, 2018
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

QurAlis Raises $5.5 million Seed Round -- Wins Pfizer Sponsored Golden Ticket to LabCentral -- -- Becomes Resident of JLABS @ LabCentral --

Brennan CaruthersNovember 19, 2018
Next

F‐star Announces Early Exercise by Denali Therapeutics of its Option to Acquire F‐star Gamma.

Brennan CaruthersMay 30, 2018

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact